Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01869738 · ClinicalTrials.gov registry record · NA
MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction
A NA study, sponsored by InspireMD.
- Terminated
- Registry status
- NA
- Development phase
- 310
- Enrollment target
NCT01869738: Clinical Trial NA study, sponsored by InspireMD.
NCT01869738 is a NA study that was terminated before completion, run by InspireMD. The registered enrollment target is 310 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01869738, a NA study, was terminated before completion, sponsored by InspireMD.
- TERMINATED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of the MGuard™ Prime stent in the treatment of blocked arteries in coronary arteries in patients undergoing a stenting procedure due to having a heart attack. The MGuard Prime stent wil be compared to other FDA approved bare-metal (BMS) or drug-eluting (DES) coronary stents. The hypotheses are that (1) the MGuard Prime stent will achieve a higher rate of complete ST-segment resolution as seen on the post-procedure ECG as compared to the comparator stent, and will have a similar effect on the rate of all-cause death or recurrent target vessel myocardial infarction at 365 days post-procedure.
Interventions
- DEVICE MGuard Prime
- DEVICE (BMS/DES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-08 |
| Phase | NA |
Why NCT01869738 stopped before completion
NCT01869738 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which MGuard Prime is the first listed.
NCT01869738 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01869738 about?
NCT01869738 is a clinical study titled "MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction". To evaluate the safety and efficacy of the MGuard™ Prime stent in the treatment of blocked arteries in coronary arteries in patients undergoing a stenting procedure due to having a heart attack. The MGuard Prime stent wil be compared to other FDA approved bare-metal (BMS) or drug-eluting (DES) coron...
What is the current status of trial NCT01869738?
This trial is currently terminated. It is a NA study. The enrollment target is 310 participants. The study started on 2013-06. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01869738?
The interventions under investigation include: MGuard Prime (DEVICE), (BMS/DES) (DEVICE).
Who is sponsoring clinical trial NCT01869738?
This trial is sponsored by InspireMD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01869738's enrollment target sits among peer trials
310 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia